Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Owl Insights Secures Strategic Investment Co-Led by Ascension Ventures & Blue Venture Fund


Owl Insights Inc., the leading provider of precision-guided behavioral health (BH) care management technology, today announced the completion of an equity financing from a syndicate of investors led by Ascension Ventures and co-led by Blue Venture Fund. In addition, First Trust Capital Partners and existing investors, including The Entrepreneurs’ Fund and Portland Seed Fund, completed the financing round.

“We are excited to have Ascension Ventures, Blue Venture Fund and First Trust Capital Partners join us as strategic investment partners at this time,” said Eric Meier, chief executive officer of Owl Insights. “This financing further validates our business strategy and momentum during what has been a very tumultuous year for the healthcare industry, with millions of Americans of all ages suffering from mental and behavioral health conditions. There has never been greater need to improve lives by harnessing innovation, technology, telehealth, and data to improve access, guide care, and truly understand the effectiveness of treatment.”

Stephen Plume, managing director of The Entrepreneurs’ Fund and the organization’s longest standing institutional investor shared, “We are very pleased with the company’s growth rate, strong reference accounts, trajectory, and impact on the behavioral health community.”

A poll conducted by Kaiser Family Foundation in July found that 53% of adults in the US said their health had been negatively impacted by COVID-19, up from 32% in March. The number of suspected overdoses unfortunately reflects this statistic as they increased 29% in April and 42% in March. But while the need for behavioral health care increases, just 43.3% of adults with mental illness receive treatment in a given year. Combined with extended waitlists and rising patient demand due to the pandemic, the burden and cost on the health system are significant, as is the need to find ways to improve and expand care delivery options.

“Ascension Ventures is excited to partner with Owl Insights on its next phase of growth,” said Victor J. Kats, managing director at Ascension Ventures. “We have been looking for innovative solutions in behavioral health for years. We were impressed by the results and impact of Owl Insights at several of our Limited Partner hospitals and we validated the need for Owl’s product portfolio in the market by surveying our hospital system partners. By working with the management team and this experienced syndicate of investors, we intend to help our provider network and the broader market appreciate the value proposition of the Owl platform and ultimately to improve behavioral health clinical quality, reduce cost and inefficiency, and delight the patient and clinician.”

Tom Hawes, MD, managing director of the Blue Venture Fund remarked, “Owl Insights’ strong growth during the past 18 months demonstrates its value proposition for improving quality through innovation in a market that has lagged behind other healthcare segments in the application of technology. We look forward to working with Ascension Ventures as strategic partners to continue to build on Owl Insights’ position in the behavioral health marketplace.”

“We see tremendous opportunity for Owl Insights to enable more successful in-person and telehealth visits,” said Victor Kats. “We also believe that by partnering with the Blue Venture Fund, Owl Insights will create new conversations and partnerships between payers and providers that offer a new way of taking care of behavioral health patients regardless of where they show up. We will be working hard to achieve this vision.”

“The stress on the behavioral health system in this country due to COVID-19 has been significant. The need for remote patient engagement and measurement-based care has never been more important. This partnership will offer the infrastructure that providers in many environments need to expand access and improve care delivery in a meaningful way,” shared Tom Insel, MD, Owl Insights advisor and mental health czar for the state of California.

About Owl Insights

Owl Insights, Inc., is the leading provider of precision-guided behavioral care management technology for behavioral health. Through its advanced platform, affectionately termed “The Owl,” the company offers a scalable strategy to integrate measurement-based care and clinical analytics into existing behavioral health treatment workflows covering all major behavioral health conditions. Owl Insights supports health systems and independent behavioral health organizations nationwide to expand access, improve quality care delivery, better manage costs, and support the preparation for value-based care. For more information, visit http://www.owlinsights.com.

About Ascension Ventures

Ascension Ventures is a strategic healthcare venture firm with four funds and more than $800 million in capital under management. The firm was launched in 2001 by Ascension, one of the nation’s largest Catholic and non-profit health systems, and today invests on behalf of twelve of the nation’s leading community health systems. These health system limited partners collectively operate more than 460 hospitals, have 572,000 employees and generate $96 billion in annual revenue. AV collaborates with these partners to identify, invest in, and support strategically aligned private companies that are transforming the healthcare industry and enhancing the experience for patients, their families and caregivers. For more information, visit http://www.ascensionventures.org.

About the Blue Venture Fund

The Blue Venture Fund is a unique collaboration among Blue Cross and Blue Shield (BCBS) companies, Blue Cross Blue Shield Association and Sandbox Industries to which thirty-six BCBS companies have committed over $800 million across four funds. The Blue Venture Fund invests in promising emerging companies of strategic relevance to BCBS companies and provides the portfolio with access to BCBS companies to deploy innovation at scale. Sandbox Industries is an independent company that provides healthcare-related investment management exclusively for the Blue Venture Fund. For more information visit http://www.BlueVentureFund.com.

Share article on social media or email:

Dentech Taps goEmerchant for Integrated Payments Delivery


Dentech, the most-trusted dental practice management software and computer technology company in the country, has tapped goEmerchant, a nationwide leader in e-commerce payment solutions, to offer a comprehensive suite of payment acceptance options.

Through its payment technology collaboration with goEmerchant, Dentech clients will be able to accept online payments from patients, safely and securely.

After evaluating potential payment providers, Dentech COO Jane Kaminski selected goEmerchant, citing the company’s nimble and tailored solutions approach, along with its rapid go-to market product offerings, including standalone and fully integrated payment methods.

“With over 40 years of service to our customers and the dental industry as a whole, we are excited for what lies ahead for us as a company, for our customers and the entire dental industry,” said Dentech COO Jane E. Kaminski. “It is my goal to not only continue the legacy that my father has built, but to also leverage modern day technology so that we can continue to provide world class solutions for our customers. We will stay committed to servicing our customers and the dental industry with the care and concern that we are known for while staying on the cutting edge of technology.”

“Dentech’s approach in helping dental providers provide the best possible patient care is comprehensive,” said goEmerchant’s Jennifer Cunningham. “To do that, they have carefully developed a practice management solution that is patient-centric. That includes giving patients an easy and secure method of paying for services, and that’s what goEmerchant does best.”

For more information, please contact Jennifer Cunningham, Manager of Key Accounts, at Jennifer.Cunningham@goEmerchant.com.

About goEmerchant

Since 1995, goEmerchant has been a leading provider of integrated payment solutions to businesses and partners of all sizes. With over 25 years of experience, goEmerchant provides robust payment solutions including in-person, online, and mobile payments, and more. goEmerchant is ranked #1 by bestcompany.com for payment providers. For more information, visit http://www.goemerchant.com.

About Dentech

Dentech is a pioneer in the advancement of dental practice management software and computer technology, serving customers nationwide for more than 40 years. For more information, visit http://www.dentech.com.

Share article on social media or email:

2020-2021 Influenza Vaccines Available for Purchase at Gulf Coast Pharmaceuticals Plus


News Image

According to the Centers for Disease Control and Prevention, September and October are the best months for immunization, so we urge everyone to visit their local vaccination facility to help protect their health during this flu season.

With the 2020-2021 flu season approaching, nationwide specialty pharmaceuticals distributor Gulf Coast Pharmaceuticals Plus (GCPP) today announced that several Influenza vaccines are now available for distribution to healthcare facilities, pharmacies, and other authorized distributors across the U.S. To purchase the vaccination kits, please contact GCPP at 888-517-3701.

The list of available Rx-only 2020-2021 Influenza vaccines includes:


  • Influenza Vaccine afluria® Quadrivalent by Seqirus (NDC 33332-320-01)


For use in persons 3 years and older

  • Influenza Vaccine afluria® Quadrivalent by Seqirus (NDC 33332-220-20)


Pediatric dose for children 6-35 months of age

  • Influenza Vaccine afluria® Quadrivalent by Seqirus (NDC 33332-420-10)


For use in persons 6 months of age and older

  • Influenza Vaccine flucelvax® Quadrivalent by Seqirus (NDC 70461-320-03)


For use in persons 4 years and older

  • Influenza Vaccine, Adjuvanted fluad® Quadrivalent by Seqirus (NDC 70461-120-03)


For use in adults 65 years and older

  • Influenza Vaccine fluarix Quadrivalent by GSK (NDC 58160-885-52)


For use in persons 6 months of age and older

  • Influenza Vaccine flulaval Quadrivalent by GSK (NDC 19515-816-52)


For use in persons 6 months of age and older

“These are some of the first vaccines available for the 2020-2021 flu season,” said GCPP Managing Director Ken Ritchey. “There is currently no vaccine available for COVID-19, which is why taking your flu shot is extremely important this year. A severe flu season combined with the ongoing coronavirus pandemic can result in what some public health officials have dubbed a “twindemic,” which could have devastating consequences. This is why we wanted to let clinics, hospitals, pharmacies, and other authorized vaccine administrators know that these vital vaccines are now available for purchase at Gulf Coast Pharmaceuticals Plus.”

Ritchey added: “According to the Centers for Disease Control and Prevention, September and October are the best months for immunization, so we urge everyone to visit their local vaccination facility to help protect their health during this flu season.”

About Gulf Coast Pharmaceuticals Plus

Gulf Coast Pharmaceuticals Plus (GCPP) is a comprehensive pharmaceutical distributor for many of the leading U.S. Pharmaceutical companies, delivering products quickly and accurately to a network of hospitals, pharmacies, and physician practices across the United States. Over the past 20 years in business, Gulf Coast Pharmaceuticals Plus has become one of the most reliable distributors of medical supplies in the nation through its quick delivery, excellent customer service, and access to over 25,000 healthcare products. Learn more about GCPP products and services at http://www.gulfcoastpharmaceuticalsplus.com, and get the latest on company news by visiting its Facebook, Twitter, and LinkedIn pages.

Share article on social media or email:



Old Trapper Introduces Zero Sugar, High Protein Beef-n-Cheese Snack Sticks for Healthy Fall and Back-to-School Snacking


Old Trapper has just put a new spin on the deli-style beef jerky for which it has become renowned. The company’s Beef-n-Cheese Snack Sticks provide the same lean beef, freshest ingredients, and wood-fired smoke that Old Trapper fans have come to love, with the unexpected twist of tasty cheese in the same convenient package. With zero sugar and 7 grams of protein per package, and because they can be taken anywhere without worry of spilling, crumbling or spoiling, the Beef-n-Cheese Snack Sticks are perfect for healthy fall, road-tripping and back-to-school snacking.

According to an article titled “The Snack Epidemic” in “Parents” magazine, “around-the-clock nibbling is hurting kids’ eating habits – and their health.” More specifically, “today kids typically eat almost three” snacks versus the typical one consumed in the late 1970s. Kids’ activities “have become overrun with chips, cookies and other snacks,” but parents can alter this trend by suggesting healthier snacks or, in the case of older kids, sending healthy snacks they love with them wherever they go.

Old Trapper is introducing a line of its premium beef sticks that makes accomplishing this goal easier than ever. Beef-n-Cheese Snack Sticks are available now so that kids can start a healthy snack habit just as school is back in session. That way, they will be ready, willing and able to turn down any unhealthy, high-sugar alternatives they encounter.

Old Trapper’s Beef-n-Cheese Snack Sticks come in two flavors: Original and Jalapeno. The Original variation features a delicious smoked beef stick that is flanked by a stick of satisfying American cheese. The Jalapeno version amps up the spiciness with Jalapeno pepper flavor and a spicy Pepper Jack cheese stick. Whether their beef and cheese are savored together or enjoyed one at a time, Beef-n-Cheese Snack Sticks bring together two different flavors in snacking unity.

The Beef-n-Cheese double-threat snack sticks from Old Trapper are available for purchase individually in grocery checkout lines and convenience stores nationwide. A 14-count box has a manufacturer’s suggested retail price of $21.

About Old Trapper Smoked Products

Old Trapper Smoked Products has produced its signature line of authentic handmade beef jerky from its headquarters in Forest Grove, Oregon since 1969. That 50 years of experience, complemented by continued investments in state-of-the-art processes, result in top-quality products that are distributed nationwide. A family-run business, Old Trapper offers a full line of high-quality, naturally smoked meat snacks using only the best lean strips of beef, the freshest seasoning ingredients and real wood-fired smoke. For more information, please visit http://www.OldTrapper.com.

Share article on social media or email:

Germinator Mobile Sanitizing and Disinfecting Launches in Rhode Island


Germinator Rhode Island will offer services to businesses and residents throughout Northern Rhode Island and its surrounding areas.

We’re looking forward to working with Matt as we enter the Rhode Island market, said Jeff Gill, CEO of Germinator. Our continued expansion has helped us to better serve communities across the U.S. during such a difficult time.

Germinator Mobile Sanitizing and Disinfecting is pleased to announce the opening of its newest franchise, Germinator Rhode Island. The location will offer services to businesses and residents throughout Northern Rhode Island and its surrounding areas, providing a 100% safe and non-toxic sanitizing and disinfecting process. The company uses breakthrough technology scientifically proven to help reduce the threat of harmful bacteria and viruses similar to the novel coronavirus.

Germinator Rhode Island will be owned and operated by Matt Banoub. Prior to launching the franchise, Matt founded Aten Energy Conservation, a Rhode Island-based weatherization company. Since 2010, Aten Energy has helped over 1,700 Rhode Island homes earn the EPA’s “Energy Star” designation. Their work over the last decade has earned Aten Energy numerous ‘Century Awards’ from the U.S. Department of Energy and the United States Environmental Protection Agency, as well as the 2019 Rhode Island SBA Microenterprise of the Year Award.

“The advancement of healthy housing and building science has been my life’s work, but 2020 presented new challenges to keeping our indoor environments safe and hygienic,” said Banoub. “Germinator Rhode Island utilizes a non-toxic treatment process to sanitize and disinfect your home or business, which is safe for you and your pets. We are committed to providing the highest quality mobile sanitizing and disinfecting services for residential, commercial and institutional clients in Northern Rhode Island and its surrounding communities.”

Since February, Germinator has been on a rapid national expansion trajectory, launching in major cities across the U.S. with more in the pipeline for the coming months. The Atlanta-based company was founded in 2015 with the vision of providing a safe, effective and non-toxic method of proper sanitizing and disinfecting for businesses and households.

“We’re looking forward to working with Matt as we enter the Rhode Island market,” said Jeff Gill, CEO of Germinator. “Our continued expansion has helped us to better serve communities across the U.S. during such a difficult time. Matt has strong leadership experience and a track record of success, making him the perfect choice to lead Germinator Rhode Island.”

Germinator utilizes a two-step process to sanitize and disinfect surfaces as well as provide long-lasting protection against odor-causing bacteria, bacteria that cause stains and discoloration, fungi such as mold and mildew, and algae. The first step — Genesis — harnesses the power of hypochlorous acid (HOCl) to destroy bacteria, mold, mildew, viruses, and odors caused by bacteria. HOCI is a non-toxic, near-neutral pH, hospital-grade sanitizer and disinfectant. The second step applies the Germinator’s Shield — an invisible microbial coating that protects surfaces for an extended period against the growth of mold, mildew, and odor-causing bacteria. Both products are EPA registered and safe for humans, pets, and the environment. The company’s highly trained field specialists employ best practices using electrostatic sprayers and wear Personal Protective Equipment (PPE) as appropriate.

Upholding the highest standards of sanitization and disinfecting, Germinator’s claims are scientifically supported and within EPA regulations. In an effort to research and further validate its practice of sanitizing and disinfecting surfaces, the company created the Germinator Scientific Advisory Board. The board is made up of key leaders such as Dr. Roscoe M. Moore, Jr – Former Assistant United States Surgeon General for five administrations.

“During these unprecedented times, the need to focus on sterilizing agents within our country’s airports, public spaces, and offices in order to decrease the spread of viral pathogens such as Coronavirus is essential,” states Dr. Moore. “I am extremely happy to be a part of the Germinator team and lend my expertise in public health and regulatory affairs to what I feel is an immense asset to the containment effort.”

The company continues to expand across the country, providing communities with a proactive solution to help free environments from harmful germs, bacteria, and viruses. Enjoy peace of mind and the freedom to live and work in a sanitized and disinfected environment. Area Businesses and residents interested in learning more can visit GerminatorRI.com or call (401) 386-3275.

Share article on social media or email:

Navigating Cancer delivers remote care innovations to keep cancer patients and oncology practices safe from COVID-19


Automatically screen patients before appointments

Automatically screen patients before appointments

Today, Navigating Cancer announced a new COVID-19 Screening Survey to automate screening before patient appointments – available free to customers using its care management solution. This new capability builds on the platform’s existing functionality that has already been delivered to help practices safely and effectively manage cancer patients through the coronavirus crisis.

Navigating Cancer, in collaboration with Merck, American Cancer Society (ACS) and Amazon Web Services (AWS), Inc., is a key component of cancer programs’ comprehensive telehealth strategy to respond to the pandemic. The company is delivering new product capabilities that enable oncology practices to more effectively manage patient and provider safety and future infectious disease events. In May, Navigating Cancer also added a COVID-19 symptom management pathway to its triage solution and enhanced its home care instructions feature so that COVID-19 information can be easily sent directly to patients via text or email. This first phase of advances was available immediately and are already in use by oncology practices across the nation.

COVID-19 has created a new level of complexity for oncology practices as they care for one of the most vulnerable populations in the country. Their processes and procedures need to evolve to ensure that their patients, their staff, and their clinics are not exposed to COVID-19 for patient safety reasons. Simultaneously, it is crucial that these clinics remain open for business in order to deliver the essential and time-critical care their patients require to receive treatment for their cancers.

“Cancer patients are one of the most vulnerable populations and their providers need all the tools they can get, especially in light of the COVID-19 pandemic,” said Mike Krepps, Principle of the American Cancer Society’s Brightedge Ventures. “We are excited to see these timely advances from Navigating Cancer. BrightEdge Ventures is the philanthropic impact fund of the American Cancer Society.”

In addition to capabilities specific to the COVID-19 response, Navigating Cancer’s cloud-based digital platform has been an important tool for care teams to maintain care continuity even during the pandemic. The application can be securely accessed by staff members working from home and includes advanced communication tools so that information can easily be delivered to entire patient populations. By leveraging AWS, Navigating Cancer is able to innovate and rapidly scale the solution for a broader swath of the cancer community as they respond to COVID-19 and prepare for potential infectious disease events in the future. Patients can also be monitored remotely via Navigating Cancer’s Health Tracker solution. This electronic patient-reported outcomes program prompts patients to report side effects, oral adherence or barriers to care they may be experiencing and helps practices proactively provide remote care and prevent unnecessary hospital visits. In an April 2020 survey on Health Tracker, 93 percent of patients reported that Health Tracker was a useful tool to get their side effects addressed.

“This expansion of Navigating Cancer’s solution for patients and providers is exciting news and a great demonstration of the innovation and scalability inherent in using AWS,” said Shez Partovi MD, Director of Worldwide Business Development for Healthcare, Life Sciences and Genomics at AWS. “We are looking forward to working with Navigating Cancer to bring the COVID-19 Screening Survey to the healthcare community as they respond to COVID-19 and prepare for potential infectious disease events in the future.”

About Navigating Cancer

Navigating Cancer is a digital health company focused on improving the lives of cancer patients and those who care for them. Our comprehensive Navigating Care platform helps providers boost their financial performance, enables more effective remote care management, and delivers a better patient experience while providing valuable insights for oncology innovation. With over 1,800 providers using the Navigating Care platform to care for over 1 million patients, it is the most broadly deployed oncology patient management solution in the US. For more information, please visit http://www.navigatingcancer.com or follow Navigating Cancer on Twitter @navcancer.

Share article on social media or email:

What You Need to Know About Pain Radiating Down Your Arms or Legs


Dr. Kaliq Chang

Radiculitis is actually a term describing the symptoms you feel when a nerve or nerve root coming from your spine is pinched, irritated, inflamed, or dysfunctional in some way.

Pain that radiates down your arms or legs is distressing enough without having to learn the odd name of the problem causing it: radiculitis. But fortunately, this extremely common scenario usually responds quickly to treatment, says Kaliq Chang, MD, of Atlantic Spine Center.

Not a condition in itself, radiculitis is actually a term describing the symptoms you feel when a nerve or nerve root coming from your spine is pinched, irritated, inflamed, or dysfunctional in some way, explains Dr. Chang, an interventional pain management specialist. The resulting pain radiates along a nerve path attached to the spinal column.

“Any part of the spine can be impacted by radiculitis, but it usually causes problems in the neck or lower back,” he says. “When you’ve got it, your pain can come and go or be present at all times. For some people, symptoms are intense.”

Causes and risk factors

Preventing radiculitis isn’t always possible. That’s because you may have various risk factors making the problem more likely to occur. According to Dr. Chang, these include:

  • You do heavy labor or participate in contact sports.
  • You have a family history of radiculitis or other spine disorders.
  • You have diabetes, which can lessen blood flow to spinal nerves.
  • You are overweight.
  • You don’t exercise often.


On the other hand, back and neck injuries from falls, car accidents, sports mishaps or even aging can all damage discs between spinal vertebrae. This damage can make nerve roots in the spine more vulnerable, triggering radiculitis, Dr. Chang says.

“Radiculitis can also result when nerves are impinged by other conditions, including arthritis, bone spurs, herniated discs, or a narrowing of the spinal canal called spinal stenosis,” he adds. “And radiculitis may include some localized back or neck pain in addition to the trademark pain, numbness and tingling it causes in the arms or legs. Sciatica – a term most people know better – actually describes radiculitis when pain radiates down the leg.”

Treatment tips

Almost always, radiculitis treatment centers on non-surgical approaches, Dr. Chang says. First, however, a comprehensive diagnostic process should be followed to pinpoint any possible triggers of radiculitis, including herniated discs or other spinal conditions. “A thorough physical exam is wise, and your doctor may decide to use various imaging scans to view what’s happening inside your back,” he adds.

According to Dr. Chang, radiculitis treatment options typically include:

  • Rest, especially after an injury that may have triggered radiculitis.
  • NSAIDs (non-steroidal anti-inflammatory drugs) such as ibuprofen or naproxen, which relieve pain, swelling and pressure.
  • Physical therapy.
  • Epidural steroid injections into the affected spinal region.


As with most spinal problems, surgery to treat radiculitis is typically reserved for only the most severe cases when less-invasive options don’t bring relief within 6 to 8 weeks, Dr. Chang notes.

“Most patients with radiculitis are able to simply look back on it as a ‘ridiculous’ episode that didn’t last long after treatment,” Dr. Chang says.

Atlantic Spine Center is a nationally recognized leader for endoscopic spine surgery with several locations in NJ and NYC. http://www.atlanticspinecenter.com, http://www.atlanticspinecenter.nyc

Kaliq Chang, MD, is an interventional pain management specialist, double board-certified in interventional pain management and anesthesiology, at Atlantic Spine Center.

Share article on social media or email:

Setton Farms partners with May Zhu, MBA, RDN, LDN of Nutrition Happens


News Image

“We are very excited to partner with May Zhu in what looks to be a record-breaking crop year,” said Setton Farms COO Mia Cohen. “May inspires us with her extensive knowledge of diet and nutrition, as well as her recipe creation and beautiful photo content promoting a healthy lifestyle.”

Setton Pistachio of Terra Bella, Inc., the nation’s second largest pistachio grower and processor based in California’s Central Valley, is partnering with May Zhu, MBA, RDN, LDN of @nutritionhappens. Zhu will serve as an ambassador for Setton Farms beginning September 2020. Nutrition Happens is a nutrition and wellness focused platform dedicated to encouraging others to live their best and healthiest lives.

Zhu is a Registered Dietitian Nutritionist based in Chicago, IL. She holds a Bachelor’s of Science in Food Science, Nutrition, and Dietetics from Clemson University. She inspires her audience to enjoy a whole food, nourishing, and nutrient-dense diet. She will promote Setton Farms’ pistachio product offerings across multiple social media channels, as well as speak to the nutritional benefits of the brand’s pistachio goods.

“We are very excited to partner with May Zhu in what looks to be a record-breaking crop year,” said Setton Farms COO Mia Cohen. “May inspires us with her extensive knowledge of diet and nutrition, as well as her recipe creation and beautiful photo content promoting a healthy lifestyle.”

“My goal as a Registered Dietitian Nutritionist is to help people feel confident about their food choices and that often starts with a conversation about why incorporating a variety of nutrient-dense foods (like pistachios!) can be beneficial for our health,” said Zhu. “I’m thrilled to be working with Setton Farms this year to show how pistachios are not only nutritious, but versatile and fun for all to enjoy.”

Setton Farms pistachio products are sold in stores nationwide, including Menards, Kroger, Wegmans, Lunds & Byerlys, Woodmans, Shoprite, Winco, Lidl, Bed Bath & Beyond, Albertson/Shaws, At Home, and online at Amazon.com.

Grown in California’s Central Valley, Setton Farms’ pistachios feature the AHA Heart-Check mark, are vegan, Non-GMO Project Verified, Certified Gluten Free, and Kosher. All of Setton Farms’ pistachios are grown, processed, and packaged using renewable energy and eco-friendly practices.

The Setton family is dedicated to providing healthy and delicious pistachio snack options that consumers of all ages love. Setton Farms produces Seasoned Pistachio Kernels, Pistachio Chewy Bites, Dark Chocolate Covered Pistachios, Premium Nut Blends, and other nutritious and delicious pistachio-based products.

For more information on Setton Farms, visit http://www.settonfarms.com or follow on social media at: Instagram @setton_farms, Facebook @settonfarmspistachiochewybites, and Twitter @settonfarms

About Setton Pistachio of Terra Bella, Inc.

Since 1986, the Setton family has taken a hands-on approach to growing and processing America’s Best Tasting Pistachios in the Central Valley of California. As the second largest pistachio processor in the United States, Setton Pistachio of Terra Bella, Inc. sustainably produces pistachios that make their way to more than 60 foreign markets. Using proprietary techniques, the Setton Farms brand offers the highest quality pistachios with a fresh-from-the-orchard taste.

Share article on social media or email:

The New England Center for Children and the Abu Dhabi Department of Education and Knowledge Agree to Renew and Extend Education Contract


The New England Center for Children

The New England Center for Children

The New England Center for Children® (NECC®), a global leader in education for children with autism, announced today an agreement with the Abu Dhabi Department of Education and Knowledge (ADEK) to renew and extend NECC’s contract for management of the Mohammed bin Rashid Center for Special Education operated by The New England Center for Children, a school and research center for children with autism spectrum disorder (ASD). Under terms of the 5-year extension, NECC will expand the school with the addition of up to 77 students, bringing the total to near 300.

Formerly known as NECC-Abu Dhabi, the Center’s name was changed to recognize the contributions of Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, who has promoted acceptance and inclusion of people of determination within the UAE under his leadership.

“We extend our utmost gratitude to Abu Dhabi’s wise leadership for their unwavering commitment to support the rich fabric of the UAE society and provide equitable education opportunities for students of determination. The expansion plan includes the development of teaching and therapy to provide opportunities for children and empower them to build independent lives,” stressed His Excellency, Amer Al Hammadi, Undersecretary of Abu Dhabi Department of Education and Knowledge, adding that the primary objective is to deliver world-class learning support, therapy and care to students of determination with autism amid increased demand for services.

“We remain committed to our mission of enabling high-quality education and providing the best opportunities for all students and we thank the families for their enduring support and cooperation. With their feedback, suggestions and efforts, we are confident in providing the right opportunities for children and empowering them to build independent lives.”

“All of us at The New England Center for Children are honored and proud to continue our relationship with Abu Dhabi,” said Vincent Strully, Jr., Founder and CEO of NECC. “The success of the school is reflected in its continued growth, and we look forward to providing world-class ABA expertise and education services to children with autism, and training UAE nationals to do the same in Arabic.”

The partnership between Abu Dhabi and NECC began in 1997, when NECC was asked to provide a private consulting program in the region. Ten years later, in 2007, NECC-Abu Dhabi was established to replicate the comprehensive range of educational services, graduate training, and research available at NECC Southborough.

NECC has been cited by the U.S. Department of Education as a model for professional development for on-site graduate training programs. NECC’s professional training program has resulted in numerous UAE nationals developing advanced skills and expertise in effective autism treatment.

Today, the Mohammed bin Rashid Center for Special Education operated by The New England Center for Children provides a full spectrum of educational services based on the proven scientific principles of applied behavior analysis (ABA) for children with ASD ages three and older. These services include early assessment and intervention to achieve best possible outcomes; preschool programming; family support services; research to support clinical best practices in education and treatment; and international consulting services.

The Center is also active in the community, supporting the Special Olympics, UAE National Sports Day, community markets, and art shows. For more information on local activities, visit https://www.facebook.com/NECCAbuDhabi/.

Over the last decade, UAE leaders and the Abu Dhabi government have aimed to offer all children the best services possible, with emphasis on education, regardless of their status or condition. The Mohammed bin Rashid Center for Special Education operated by The New England Center for Children continues this practice by offering the world’s best education services to UAE National children affected by autism.

About Abu Dhabi Department of Education and Knowledge (ADEK)

The Abu Dhabi Department of Education and Knowledge (ADEK) is the Education Sector regulator across the Emirate. It oversees and provides services throughout a learner’s journey from early education to university and beyond. It also champions inclusivity for People of Determination in the mainstream schooling system and by providing specialized schools.

Across Early Childhood and K-12, ADEK licenses and regulates nurseries and private schools in Abu Dhabi while also legislating, mandating and managing its own Charter Schools and 2 schools for People of Determination.

ADEK also annually provides distinguished Abu Dhabi students with full scholarships and support to study at the best universities around the world. In addition, the Department audits and enhances the delivery of Higher Education in Abu Dhabi, attracting Higher Education Institutions to open the required programs or schools that serve Abu Dhabi’s needs while championing a student and faculty-friendly ecosystem in the Emirate.

About The New England Center for Children

The New England Center for Children® (NECC®) is an award-winning autism education center and research institute. Our community of teachers, researchers, and clinicians have transformed the lives of thousands of children with autism worldwide through education, research, and technology. The Center provides comprehensive services to maximize independence: home-based, day, and residential programs, partner classrooms in public school systems, consulting services, the ACE® ABA Software System (http://www.acenecc.org), teacher professional development, and research on educational best practices.

NECC is committed to staff professional development, partnering with local colleges to provide on-site graduate training and degrees at little to no cost to the NECC teacher. The result is a growing pool of exceptional teachers trained in best-in-class methodologies, whether they continue their careers at NECC or move on to public schools or private agencies. The New England Center for Children is based in Southborough, MA. Learn more at http://www.necc.org.

Share article on social media or email:

Invistics Announces Major Upgrades to its Drug Diversion Solutions for Healthcare Organizations


News Image

The longer a healthcare worker diverts drugs, the more patients can be put at risk

Invistics, the leading provider of advanced inventory visibility and analytics software, has released the latest major update of Invistics’ Flowlytics software, including new features for healthcare systems drug diversion solutions. These capabilities allow organizations to integrate data from multiple IT systems across departments and facilities, including inpatient healthcare facilities, as well as ambulatory and outpatient operations such as retail pharmacies, ambulatory surgical centers, and infusion centers.

Healthcare organizations benefit from the ability to uncover potential diversion across departments and facilities and surface potential thefts quickly — in days, or even hours –reducing the time it takes to discover potential drug diversion. Flowlytics, unique among existing drug diversion solutions, can also help detect more incidents overall by tracking medications from the wholesaler purchase all the way through the organization until they are administered to patients or safely destroyed.

Drug diversion expert Russ Nix, founder of Aegis RX, says the speed of detection is critical in healthcare facilities to protect patients from risk. “The time between when a drug diversion incident occurs and when it is adjudicated is extremely valuable. The longer a healthcare worker diverts drugs, the more patients can be put at risk,” said Nix. “Now, Invistics has added those same drug diversion detection capabilities to multiple departments and facilities, creating a network of data that can expose more potential diversion incidents with speed and accuracy.”

The new Flowlytics features provide the following additional benefits:


  • More efficient investigation: Permitted users can now review Personally Identifiable Information (PII) within the software, with full Health Insurance Portability and Accountability Act (HIPAA) compliance.
  • Improved usability: All modules are now logically aligned with drug diversion prevention workflow best practices: detection, investigation, adjudication and reporting. This alignment of reports with workflow steps will make it easier for staff to investigate diversion, with a full audit trail of investigation notes and information.
  • Improved data security: Health systems with multiple locations can use Data Access Levels to allow some drug diversion investigators to see all data, while limiting data visibility for others to specific locations or departments.

“Invistics is in a unique place to solve drug diversion issues for healthcare organizations, with a long history of providing solutions that optimize inventory and make it continually visible across multiple departments, businesses and IT systems in complex, global supply chains,” said Invistics founder and Chief Executive Officer, Tom Knight. “These leaky supply chains also exist in healthcare organizations, where inventory includes controlled substances and expensive oncology drugs and biologics. We are applying advanced analytics and machine learning to help detect drug diversion quickly and efficiently, while significantly reducing the hassles of regulatory reporting—issues that every healthcare organization needs to address.”

About Invistics

Invistics is the leading provider of cloud-based drug diversion solutions for healthcare inventory visibility, providing advanced analytics and actionable insights for hospitals and health systems who want to detect and prevent drug diversion. Invistics’ solution, called Flowlytics®, tracks the movement of drugs across the complex supply chain – from the time they are shipped from the wholesaler to a healthcare facility, then each time drugs are moved throughout the hospital and administered to patients. Atlanta-based Invistics Corporation also provides inventory visibility for manufacturers, distributors, re-packagers and controlled substance registrants, helping to reduce inventory costs and compliance risks within a single facility or across the extended enterprise. To learn more, visit https://www.invistics.com.

Share article on social media or email: